SYMBIOTA™

RESET MICROBIOME – Connecting Synergy to Systemic Wellness

The microbiome is more than a collection of microorganisms. It is a dynamic ecosystem whose balance influences how the body responds, adapts, and thrives.

SYMBIOTA™ is MICROBIO’s proprietary precision microbiome platform—designed to reset microbiome synergy through controlled microbial ecosystems and symbiotic fermentation. By transforming complex microbial interactions into stable, high-value postbiotic ingredients, we help create solutions that connect gut health with broader systemic wellness.

SYMBIOTA™ Health Technology 5.0 platform combining Precision Pathology Targeting and Multi-Strain Symbiotic Fermentation to deliver precise health outcomes through advanced microbiome technology.

From Disruption to Synergy

Modern lifestyles can challenge microbiome resilience. Diet, stress, medications, and environmental exposure may disrupt the microbial interactions that help support health.

Fecal microbiota transplantation (FMT) has demonstrated the importance of the microbiome as an interconnected community—not simply individual strains, but the way microbes function together within an ecosystem.

 

SYMBIOTA™ applies this ecosystem principle to product development through a controlled fermentation approach. Carefully selected microorganisms grow and interact through true multi-strain symbiotic co-fermentation, generating a diverse spectrum of bioactive metabolites. No fecal material is used, and the approach does not rely on live microbial colonization.

RESET MICROBIOME is not about starting over. It is about supporting the conditions for a more balanced, responsive, and connected microbial ecosystem—Connecting Synergy to Systemic Wellness.

Beyond the Limits of Conventional Biotics

For many consumers, taking a conventional biotic does not always lead to noticeable or consistent benefits. Outcomes can vary depending on an individual’s baseline microbiome, the relevance of the selected strain, and whether live microorganisms remain viable through manufacturing, shelf life, formulation, and the digestive journey.

Rather than simply adding beneficial bacteria, SYMBIOTA™ creates bioactive postbiotic ingredients from microbial collaboration. This ecosystem-driven approach delivers stable, formulation-flexible solutions designed to support microbiome balance and targeted physiological functions—opening broader opportunities than conventional live probiotic formats.

SYMBIOTA™ Microbiome RESET Engine uses precision microbiome design and multi-strain symbiotic fermentation to rebuild a controlled microbial ecosystem, beyond traditional probiotics and conventional postbiotic approaches.

What Makes Symbiota™ Different?

A Precision Microbiome Platform Designed Beyond Conventional Postbiotics

SYMBIOTA™ combines precision microbial selection with proprietary multi-strain symbiotic fermentation to create differentiated postbiotic ingredients.
By leveraging microbial interactions within a controlled fermentation ecosystem, SYMBIOTA™ generates diverse bioactive compounds designed to support targeted health and wellness applications.

Key Technology Advantages

  • Multi-strain synergy
  • Complete metabolite profile
  • Nano-sized metabolites
  • Stable & flexible formulation
  • Over 20 international patents
  • More than 1,600 microbial solution libraries

 

From Scientific Innovation to Market-Ready Solutions

Backed by over two decades of pharmaceutical and microbiome research, SYMBIOTA™ transforms precision fermentation into high-value postbiotic ingredients.

With scalable manufacturing, international patent protection, Halal-certified and a U.S. GRAS-supported market strategy, SYMBIOTA™ is positioned to bring microbiome innovation to markets worldwide.

GRAS認證

Explore the Symbiota™ Ingredients- Connecting Synergy to Systemic Wellness

The microbiome does not work in isolation. Its influence extends through interconnected pathways across the body.

Discover how SYMBIOTA™ ingredients connect microbial synergy to targeted wellness solutions.

Commercial Success Stories

From Platform Innovation to Market-Proven Products

From pharmaceutical innovation to consumer wellness solutions, SYMBIOTA™ has demonstrated successful commercialization across multiple product categories. These market-proven applications highlight the versatility and scalability of Microbio’s microbiome platform, transforming scientific innovation into commercially successful products.

中天生技上療漾產品

Pharmaceutical Applications

Chemo young (MS-20)

Developed through over a decade of research and development, Chemo Young is an oral therapy approved in Taiwan as an adjuvant treatment for cancer patients. Built upon the scientific foundation of SYMBIOTA™, MS-20 represents a significant milestone in the translation of microbiome research into pharmaceutical innovation.

 

Digestive Health & Wellness

“Tien Chun Bao” Prime Enzyme

A consumer health product formulated with SYMBIOTA™ technology to support digestive wellness and microbiome balance. Prime Enzyme demonstrates how microbiome-derived ingredients can be incorporated into everyday nutritional solutions designed for a broad range of consumers.

田中寶原生漾酵酶
清醍醐養生液獲得三項小綠人認證

Microsoy

Combining traditional fermentation expertise with modern microbiome science, Microsoy has become a recognized health food product supporting digestive and overall wellness. Its success highlights the adaptability of SYMBIOTA™ technology across functional food applications.

Young

Developed using advanced fermentation technologies, Young is designed to support digestive wellness and overall health maintenance. The product reflects the potential of SYMBIOTA™ technology in creating innovative consumer health solutions based on microbiome science.

田中保養生液獲得三項小綠人認證